The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by de Beurs, E.
* Articles by van Dyck, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by de Beurs, E.
* Articles by van Dyck, R.

Am J Psychiatry 1995; 152:683-691
Copyright © 1995 by American Psychiatric Association


BRIEF REPORTS

Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone

E de Beurs, AJ van Balkom, A Lange, P Koele and R van Dyck
Department of Clinical Psychology, University of Amsterdam, The Netherlands.

OBJECTIVE: The purpose of this comparative outcome study was to investigate whether the effects of exposure in vivo treatment for panic disorder with agoraphobia could be enhanced by adding interventions specifically for panic attacks before the start of exposure treatment. The additional effect of two types of treatment for panic attacks-- pharmacological (fluvoxamine) and psychological (repeated hyperventilation provocations and respiratory training)--was examined. Thus, the combined treatment of panic interventions with exposure in vivo could be compared to exposure in vivo alone. METHOD: Ninety-six patients were randomly assigned to four treatment conditions: double- blind, placebo-controlled fluvoxamine followed by exposure in vivo, psychological panic management followed by exposure, and exposure in vivo alone. Outcome was assessed by self-report measures, a standardized multitask behavioral avoidance test, and continuous monitoring of panic attacks. Seventy-six patients completed the study. RESULTS: All four treatments were effective and resulted in a significant decrease of agoraphobic avoidance. Moreover, the combination of fluvoxamine and exposure in vivo demonstrated efficacy superior to that of the other treatments and had twice as large an effect size (difference between pre- and posttreatment scores) on self- reported agoraphobic avoidance. The other treatments did not differ among each other in effectiveness. CONCLUSIONS: Results of the study indicate that the short-term outcome of exposure in vivo treatment can be enhanced by adding fluvoxamine treatment. Psychological panic management combined with exposure was not superior to exposure alone of equal duration.


This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
T. A. FURUKAWA, N. WATANABE, and R. CHURCHILL
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review
The British Journal of Psychiatry, April 1, 2006; 188(4): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
M. E. Wylie, M. D. Miller, M. K. Shear, J. T. Little, B. H. Mulsant, B. G. Pollock, and C. F. Reynolds
Fluvoxamine Pharmacotherapy of Anxiety Disorders in Later Life: Preliminary Open-Trial Data
J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 43 - 48.
[Abstract] [PDF]


Home page
J. Psychother. Pract. Res.Home page
S. G. Hofmann and D. A. Spiegel
Panic Control Treatment and Its Applications
J Psychother Pract Res., January 1, 1999; 8(1): 3 - 11.
[Abstract] [Full Text]


Home page
DTBHome page
Stopping panic attacks
DTB, August 1, 1997; 35(8): 58 - 62.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. M. Sharp and K. G. Power
Reviews : Treatment-outcome research in panic disorder: dilemmas in reconciling the demands of pharmacological and psychological methodologies
J Psychopharmacol, January 1, 1997; 11(4): 373 - 380.
[Abstract] [PDF]


Home page
JWatch PsychiatryHome page
Optimizing Effective Treatments for Anxiety Disorders
Journal Watch Psychiatry, July 1, 1995; 1995(701): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1995 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org